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Background
Spider dragline silk is considered to be the toughest biopo-
lymer on Earth due to an extraordinary combination of
strength and elasticity. With synthetic biology it is possible
to express recombinant spider silk proteins, which are
characterized by a highly repetitive rich glycine and
alanine sequence [1]. However, production of high mole-
cular weight spider silk protein can be difficult due to
DNA instability, transcription and translation errors. Here
we show, for the first time, Masp2 (105 kDa) spidroin silk
protein production from the Brazilian spider Parawixia
bistriata in different metabolically engineered E.coli
strains.
Methods
A Masp2 monomer gene from P. bistriata was designed
(DNA2.0), and a 32 mer plasmid was constructed [2]. To
increase the glycyl-tRNA pool, tRNAGly and glycyl-tRNA
synthetase genes were cloned in pACYC184 plasmid [3].
All vectors were confirmed by DNA sequencing. The bac-
terium BL21(DE03) was co-tranformed with the 32 mer
and one metabolic plasmid. pACYC184 and pET19b vec-
tors was used as controls. Cells were grown in a 2L flask
culture with 1L of LB medium with antibiotics, at 37°C
and 200 rpm. Silk proteins were induced with 1 mM
IPTG, for four hours, and growth curves were established.
Protein histag N-terminal extraction was performed under
native conditions and purified by IMAC. All samples were
analyzed by SDS-PAGE gels, staining with Colloidal Blue
and by Western blot. Dialysis was at 4°C against 10 mM
Tris-HCl pH 8.0 for the first 24 hours, and water for an
additional 24 hours. Samples were lyophilized and
weighed. Statistical analyses were determined by ANOVA
and unpaired Tukey test (ASSISTAT 7.7 BETA 2013),
bein statistically significant at P<0.01.
Results and conclusions
All E. coli that received Masp2 grew, expressing spider
protein, and data yields are shown in table 1 (N = 3).
There were no expression differences between BL21
(DE03) and pACYC184, nor in the strain containing one
gene copy to increase tRNAGly pool. This shows no inter-
ference from the initial plasmid used for bacterial meta-
bolic engineering. The amount of tRNA was probably not
enough to supply the metabolic stress. When the tRNAGly
and glycine pool were overexpressed by ptetgly2,
pTetglyVXY-glyA and pTetgly2-glyA, an improvement
was noted in the production of 105 kDa Masp2 (P <0.01).
In similar studies, the same synergistic effect was reported
for high molecular weight protein from Nephila clavipes
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Table 1 Spider silk Masp2 protein yield in different
engineered E.coli
Bacteria Means *
pTetgly2-glyA 3.39 a
pTetglyVXY-glyA 2.83 ab
pTetgly2 2.40 b
pTetglyVXY 0.96 c
pACYC184 0.99 c
BL21(DE03) 0.79 c
Means reference: mg protein/g pellet. P < 0.01; CV = 13.72%
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[3]. The same authors also reported that protein sizes are
directly associated with fiber quality properties. The 105
kDa Masp2 produced was able to be spun in fibers, which
will be characterized in future analyses. Currently, there is
no ideal heterologous organism to produce spider silk
proteins, and metabolic engineering together with syn-
thetic biology can optimize spider silk protein production.
Different spider silk proteins may result in new types of
protein-based biomaterials with wide applications in medi-
cine and industry.
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